The reduction in CD44v6 was accompanied by decreased levels of CD44, CD24, and CD133, which are widely recognized as key CSC markers involved in regulating self-renewal, differentiation potential, and tumor aggressiveness (p < 0.001). This evidence concerns the gene CD44 and neoplasm.